|
Video: What is a Stock Split?
|
|
Aptorum Group Limited is a United Kingdom-based clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. According to our APM split history records, Aptorum Group has had 1 split. | |
|
Aptorum Group (APM) has 1 split in our APM split history database. The split for APM took place on January 23, 2023. This was a 1 for 10 reverse split, meaning for each 10 shares of APM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Aptorum Group conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the APM split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aptorum Group shares, starting with a $10,000 purchase of APM, presented on a split-history-adjusted basis factoring in the complete APM split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/19/2018 |
|
End date: |
12/09/2024 |
|
Start price/share: |
$135.10 |
|
End price/share: |
$0.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.39% |
|
Average Annual Total Return: |
-57.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$60.72 |
|
Years: |
5.98 |
|
|
|
Date |
Ratio |
01/23/2023 | 1 for 10 |
|
|